June 25, 2018
Kowa has filed a lawsuit with the Tokyo District Court related to generic versions of the hypercholesterolemia treatment Livalo (pitavastatin) seeking approximately 3.8 billion yen in damages from Towa Pharmaceutical. Towa announced on June 22 that it received the complaint...read more